The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies-Reference-Cited by-同舟云学术

The prognostic and therapeutic potentials of CTLA-4 in hematological malignancies

Published:2022-12-02 Issue:12 Volume:26 Page:1057-1071
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Sadeghi Mohammad¹,Khodakarami Atefeh²,Ahmadi Armin³,Fathi Mehrdad¹,Gholizadeh Navashenaq Jamshid⁴^ORCID,Mohammadi Hamed⁵^ORCID,Yousefi Mehdi⁶,Hojjat-Farsangi Mohammad⁷^ORCID,Movasaghpour Akbari Ali Akbar⁸,Jadidi-Niaragh Farhad¹⁹

Affiliation:

1. Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

2. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

3. Department of Chemical and Materials Engineering, the University of Alabama in Huntsville, Huntsville, Alabama, USA

4. Noncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran

5. Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran

6. Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

7. Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

8. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

9. Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

Funder

Tabriz University of Medical Sciences

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2022.2170781

Reference85 articles.

1. Leukemia

2. The WHO Classification of Haematolymphoid Tumours

3. Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies

4. Stem cell gene expression programs influence clinical outcome in human leukemia

5. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning;Heliyon;2024-08

2. Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance;Cell Communication and Signaling;2024-06-19

3. The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy;MedComm – Oncology;2024-03

4. Prediction of myeloid malignant cells in Fanconi anemia using machine learning;2024-01-02